Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dmitriy S. Ruyatkin"'
Publikováno v:
Ожирение и метаболизм, Vol 17, Iss 1, Pp 41-47 (2020)
The high prevalence of metabolic syndrome (MS) and subclinical hypothyroidism (SHypo) creates danger of integral cardio-metabolic risk (CMR). A concept is being developed to increase thyroid-stimulating hormone (TSH) levels as a component of MS with
Externí odkaz:
https://doaj.org/article/594bf30ae4a3425fbe3af2163f24b3d8
Publikováno v:
Сахарный диабет, Vol 20, Iss 3, Pp 210-219 (2017)
In modern algorithms for the treatment of type 2 diabetes, metformin is positioned as a first-line drug, which, when the disease progresses, is universally combined with other groups of hypoglycemic drugs, including insulin. Review of literature demo
Externí odkaz:
https://doaj.org/article/42c44c268da24bf5b6a47d750c9d373d
Publikováno v:
Ожирение и метаболизм, Vol 17, Iss 1, Pp 41-47 (2020)
The high prevalence of metabolic syndrome (MS) and subclinical hypothyroidism (SHypo) creates danger of integral cardio-metabolic risk (CMR). A concept is being developed to increase thyroid-stimulating hormone (TSH) levels as a component of MS with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29bd25463f57c7154e7a7e3e6f44c582
https://doi.org/10.14341/omet12282
https://doi.org/10.14341/omet12282
Publikováno v:
Сахарный диабет, Vol 20, Iss 3, Pp 210-219 (2017)
In modern algorithms for the treatment of type 2 diabetes, metformin is positioned as a first-line drug, which, when the disease progresses, is universally combined with other groups of hypoglycemic drugs, including insulin. Review of literature demo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a1ff1611ad27a4e85999968d690d12d
https://doi.org/10.14341/dm2003458-64
https://doi.org/10.14341/dm2003458-64
Autor:
Konstantin Yuryevich Nikolaev, Lyudmila Aleksandrovna Ruyatkina, Irina S. Iskhakova, Dmitriy S. Ruyatkin
Publikováno v:
Сахарный диабет, Vol 18, Iss 4, Pp 105-112 (2015)
Most of the questions regarding vascular and rheological regulation related to normal health and disorders of carbohydrate metabolism remain unclear, which is important in the pathogenesis of angiopathy. Consequently, in the literature, there is no i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4a6dc09420e12f8943b5db161e4691
https://doi.org/10.14341/dm7561
https://doi.org/10.14341/dm7561